• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非肝硬化性闭塞性门静脉病在伴有门静脉高压的小儿囊性纤维化肝病中普遍存在。

Obliterative Portal Venopathy Without Cirrhosis Is Prevalent in Pediatric Cystic Fibrosis Liver Disease With Portal Hypertension.

机构信息

Department of Pathology, Baylor College of Medicine, Houston, Texas.

Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas.

出版信息

Clin Gastroenterol Hepatol. 2019 Sep;17(10):2134-2136. doi: 10.1016/j.cgh.2018.10.046. Epub 2018 Nov 4.

DOI:10.1016/j.cgh.2018.10.046
PMID:30404037
Abstract

Cystic fibrosis liver disease (CFLD) has long been postulated to be secondary to dysfunctional cystic fibrosis transmembrane conductance regulator in the apical biliary epithelium, leading to bile stasis and eventually cirrhosis with portal hypertension. However, pathologic changes in the cystic fibrosis (CF) liver are distinct from the pancreas and lungs in that fibrocystic changes are absent. Furthermore, the lack of clinically evident biliary obstruction and liver dysfunction suggest there may be alternative mechanisms that contribute to CFLD. Two recent studies in young adults described obliterative portal venopathy (OPV) and noncirrhotic portal hypertension (NCPH) as the predominant pathophysiology in young adults (median, 22 y) with CFLD. It is unknown if OPV develops early in childhood. Herein, we report the clinical features and liver pathology in 17 explants from children and adolescents with CF, representing 13.6% (17 of 125) of the CF liver transplant population in the United States according to the United Network for Organ Sharing and Organ Procurement and Transplantation Network.

摘要

囊性纤维化肝病(CFLD)长期以来被认为是由于顶端胆管上皮中囊性纤维化跨膜电导调节因子功能障碍导致胆汁淤积,最终导致肝硬化和门静脉高压。然而,囊性纤维化(CF)肝脏的病理变化与胰腺和肺部不同,不存在纤维囊性变化。此外,缺乏明显的临床胆道梗阻和肝功能障碍表明,可能存在其他导致 CFLD 的机制。最近两项针对年轻成年人的研究描述了闭塞性门静脉病(OPV)和非肝硬化性门静脉高压(NCPH)是年轻成年人(中位年龄 22 岁)CFLD 的主要病理生理学。目前尚不清楚 OPV 是否在儿童期早期发生。在此,我们报告了美国器官共享联合网络和器官获取和移植网络中 17 名 CF 儿童和青少年肝移植供体的临床特征和肝脏病理学,占美国 CF 肝移植人群的 13.6%(17/125)。

相似文献

1
Obliterative Portal Venopathy Without Cirrhosis Is Prevalent in Pediatric Cystic Fibrosis Liver Disease With Portal Hypertension.非肝硬化性闭塞性门静脉病在伴有门静脉高压的小儿囊性纤维化肝病中普遍存在。
Clin Gastroenterol Hepatol. 2019 Sep;17(10):2134-2136. doi: 10.1016/j.cgh.2018.10.046. Epub 2018 Nov 4.
2
Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy.肝硬化前期胆道疾病中的肝移植:门静脉高压常与结节性再生性增生和闭塞性门静脉病相关。
Am J Surg Pathol. 2006 Nov;30(11):1454-61. doi: 10.1097/01.pas.0000213286.65907.ea.
3
Non-cirrhotic portal hypertension (obliterative portal venopathy) is the predominant form of chronic liver disease in cystic fibrosis.非肝硬化性门静脉高压(闭塞性门静脉病)是囊性纤维化中慢性肝病的主要形式。
Ir J Med Sci. 2023 Aug;192(4):1657-1660. doi: 10.1007/s11845-022-03153-0. Epub 2022 Sep 17.
4
Liver transplantation in adult cystic fibrosis: Clinical, imaging, and pathological evidence of obliterative portal venopathy.成人囊性纤维化患者的肝移植:闭塞性门静脉病的临床、影像学及病理证据
Liver Transpl. 2017 Oct;23(10):1342-1347. doi: 10.1002/lt.24842.
5
Features of Severe Liver Disease With Portal Hypertension in Patients With Cystic Fibrosis.囊性纤维化患者严重肝病伴门静脉高压的特征
Clin Gastroenterol Hepatol. 2016 Aug;14(8):1207-1215.e3. doi: 10.1016/j.cgh.2016.03.041. Epub 2016 Apr 5.
6
SERPINA1 Z allele is associated with cystic fibrosis liver disease.丝氨酸蛋白酶抑制剂 A1(SERPINA1)Z 等位基因与囊性纤维化肝病有关。
Genet Med. 2019 Sep;21(9):2151-2155. doi: 10.1038/s41436-019-0449-6. Epub 2019 Feb 11.
7
Emerging clinical perspectives in cystic fibrosis liver disease.囊性纤维化肝病的新兴临床观点。
Curr Opin Pulm Med. 2021 Nov 1;27(6):593-599. doi: 10.1097/MCP.0000000000000824.
8
The non-invasive evaluation of liver involvement in patients with cystic fibrosis: A prospective study.囊性纤维化患者肝脏受累的非侵入性评估:一项前瞻性研究。
Liver Int. 2023 Nov;43(11):2492-2502. doi: 10.1111/liv.15748. Epub 2023 Sep 19.
9
Obliterative portal venopathy without portal hypertension: an underestimated condition.无门静脉高压的闭塞性门静脉病:一种被低估的病症。
Liver Int. 2016 Mar;36(3):454-60. doi: 10.1111/liv.12936. Epub 2015 Sep 6.
10
Pathology of idiopathic non-cirrhotic portal hypertension.特发性非肝硬化性门静脉高压症的病理学。
Virchows Arch. 2018 Jul;473(1):23-31. doi: 10.1007/s00428-018-2355-8. Epub 2018 Apr 12.

引用本文的文献

1
New guidelines for screening, evaluation and management of hepatobiliary disease in cystic fibrosis.囊性纤维化肝胆疾病筛查、评估及管理新指南
Hepatobiliary Surg Nutr. 2024 Oct 1;13(5):875-878. doi: 10.21037/hbsn-24-442. Epub 2024 Sep 26.
2
Cystic fibrosis hepatobiliary involvement: an update on imaging in diagnosis and monitoring.囊性纤维化肝胆受累:诊断和监测中影像学的最新进展。
Pediatr Radiol. 2024 Aug;54(9):1416-1427. doi: 10.1007/s00247-024-05979-5. Epub 2024 Jul 22.
3
Genetic variation in severe cystic fibrosis liver disease is associated with novel mechanisms for disease pathogenesis.
严重囊性纤维化肝病的遗传变异与疾病发病机制的新机制有关。
Hepatology. 2024 Nov 1;80(5):1012-1025. doi: 10.1097/HEP.0000000000000863. Epub 2024 Mar 27.
4
Alterations in the fecal microbiota in patients with advanced cystic fibrosis liver disease after 6 months of elexacaftor/tezacaftor/ivacaftor.接受伊伐卡托/泰他卡托/艾维雷司他治疗 6 个月后,晚期囊性纤维化肝病患者粪便微生物群的改变。
J Cyst Fibros. 2024 May;23(3):490-498. doi: 10.1016/j.jcf.2024.02.015. Epub 2024 Mar 6.
5
Improving detection of cystic fibrosis related liver disease using liver fibrosis assessment tools.使用肝纤维化评估工具改善囊性纤维化相关肝病的检测
Heliyon. 2023 Nov 7;9(11):e21861. doi: 10.1016/j.heliyon.2023.e21861. eCollection 2023 Nov.
6
Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations.囊性纤维化肝胆道疾病筛查、评估和管理的共识建议。
Hepatology. 2024 May 1;79(5):1220-1238. doi: 10.1097/HEP.0000000000000646. Epub 2023 Oct 26.
7
Heterogeneous liver on research ultrasound identifies children with cystic fibrosis at high risk of advanced liver disease.研究超声中的肝不均匀性可识别出囊性纤维化患儿中存在进展性肝病高危风险者。
J Cyst Fibros. 2023 Jul;22(4):745-755. doi: 10.1016/j.jcf.2023.03.019. Epub 2023 Apr 7.
8
Pre-emptive transjugular intrahepatic portosystemic shunt in pediatric cystic fibrosis-related liver disease and portal hypertension: prospective long-term results.小儿囊性纤维化相关性肝病和门静脉高压症的预防性经颈静脉肝内门体分流术:前瞻性长期结果。
Diagn Interv Radiol. 2024 Jan 8;30(1):55-64. doi: 10.4274/dir.2022.221818. Epub 2023 Mar 20.
9
Non-cirrhotic portal hypertension (obliterative portal venopathy) is the predominant form of chronic liver disease in cystic fibrosis.非肝硬化性门静脉高压(闭塞性门静脉病)是囊性纤维化中慢性肝病的主要形式。
Ir J Med Sci. 2023 Aug;192(4):1657-1660. doi: 10.1007/s11845-022-03153-0. Epub 2022 Sep 17.
10
Role of transient elastography and APRI in the assessment of pediatric cystic fibrosis liver disease.瞬时弹性成像和APRI在小儿囊性纤维化肝病评估中的作用。
Can Liver J. 2021 Feb 24;4(1):23-32. doi: 10.3138/canlivj-2020-0008. eCollection 2021 Winter.